β-chemokine production in macaques vaccinated with live attenuated virus correlates with protection against simian immunodeficiency virus (SIVsm) challenge
Simian immunodeficiency virus (SIV) uses the CCR5 chemokine receptor as the main co-receptor to enter CD4+ cells. RANTES, MIP-1alpha and MIP-1beta have been suggested as the major human immunodeficiency virus-suppressor factors produced by CD8+ T-cells. The aim of this study was to investigate the CD8+ T-cell production of anti-viral factors and of beta-chemokines in six cynomolgus macaques vaccinated with live attenuated SIVmacC8 in relation to protection against infectious intrarectal SIVsm challenge. Three of the vaccinated animals were completely protected and one was partially protected against the challenge virus. Interestingly, these monkeys showed higher in vitro anti-viral CD8+ cell suppressor activity and beta-chemokine production both before and after vaccination as compared to the infected monkeys. The results indicate that beta-chemokines may play a role in protective immunity but also that genetic and/or environmental factors may influence their production.
AlkhatibG.,
CombadiereC.,
BroderC. C.,
FengY.,
KennedyP. E.,
MurphyP. M.,
BergerE. A.1996; CC CKR-5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272:1955–1958
AnderssonS.,
MäkitaloB.,
ThorstenssonR.,
FranchiniG.,
TartagliaJ.,
LimbachK.,
PaolettiE.,
PutkonenP.,
BiberfeldG.1996; Immunogenicity and protective efficacy of a human immunodeficiency virus type 2 recombinant canarypox (ALVAC) vaccine candidate in cynomolgus monkeys. Journal of Infectious Diseases 174:977–985
BlackbournD. J.,
LocherC. P.,
RamachandranB.,
BarnettS. W.,
MurthyK. K.,
CareyK. D.,
BraskyK. M.,
LevyJ. A.1997; CD8+ cells from HIV-2 infected baboons control HIV replication. AIDS 11:737–746
ChenZ.,
ZhouP.,
HoD. D.,
LandauN. R.,
MarxP. A.1997; Genetically divergent strains of simian immunodeficiency viruses use CCR5 as a coreceptor for entry. Journal of Virology 71:2705–2714
CocchiF.,
DeVicoA. L.,
Garzino-DemoA.,
ArayaS. K.,
GalloR. C.,
LussoP.1995; Identification of RANTES, MIP-1α and MIP-1β as the major HIV-suppressive factors produced by CD8+ cells. Science 270:1811–1815
DengH.,
LiuR.,
EllmeierW.,
ChoeS.,
UnutmazD.,
BurkhartM.,
Di MarzioP.,
MarmonS.,
SuttonR. E.,
HillC. M.,
DavisC. B.,
PeiperS. C.,
SchallT. J.,
LittmanD. R.,
LandauN. R.1996; Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661–666
DengH.,
UnutmazD.,
KewalRamaniV. N.,
LittmanD. R.1997; Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 388:296–300
DragicT.,
LitwinV.,
AllawayG. P.,
MartinS. R.,
HuangY.,
NagashimaK. A.,
CayananC.,
MaddonP. J.,
KoupR. A.,
MooreJ. P.,
PaxtonW. A.1996; HIV-1 entry into CD4 + cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667–673
EnnenJ.,
FindekleeH.,
DittmarM. T.,
NorleyS.,
ErnstM.,
KurthR.1994; CD8+ T lymphocytes of African green monkeys secrete an immunodeficiency virus-suppressing lymphokine. Proceedings of the National Academy of Sciences, USA 91:7207–7211
HeeneyJ. L.,
TeeuwsenV. J. P.,
Van GilsM.,
BogersW. M. J. M.,
De Giuli MorghenC.,
RadaelliA.,
BarnettS.,
MoreinB.,
AkerblomL.,
WangY.,
LehnerT.,
DavisD.1998; β-Chemokines and neutralizing antibody titers correlate with sterilizing immunity generated in HIV-1 vaccinated macaques. Proceedings of the National Academy of Sciences, USA 95:10803–10808
HillC. M.,
DengH.,
UnutmazD.,
KewalRamaniV. N.,
BastianiL.,
GornyM. K.,
Zolla-PaznerS.,
LittmanD. R.1997; Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interaction with this chemokine receptor. Journal of Virology 71:6296–6304
KannagiM.,
ChalifouxL. V.,
LordC. I.,
LetvinN. L.1988; Suppression of simian immunodeficiency virus replication in vitro by CD8+ lymphocytes. Journal of Immunology 140:2237–2242
KinterA. L.,
OstrowskiM.,
GolettiD.,
OlivaA.,
WeissmanD.,
GanttK.,
HardyE.,
JacksonR.,
EhlerL.,
FauciA. S.1996; HIV replication in CD4 + T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous β-chemokines and the viral inductive effects of other endogenous cytokines. Proceedings of the National Academy of Sciences, USA 93:14076–14081
LandayA. L.,
MackewiczC. E.,
LevyJ. A.1993; An activated CD8+ T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status. Clinical Immunology & Immunopatholgy 69:106–116
LevyJ. A.,
MackewiczC. E.,
BarkerE.1996; Controlling HIV pathogenesis: the role of noncytotoxic anti-HIV response of CD8+ T cells. Immunology Today 17:217–224
LiuR.,
PaxtonW. A.,
ChoeS.,
CeradiniD.,
MartinS. R.,
HorukR.,
MacDonaldM. E.,
StuhlmannH.,
KoupR. A.,
LandauN. R.1996; Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86:367–377
MackewiczC. E.,
BlackbornD. J.,
LevyJ. A.1995; CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription. Proceedings of the National Academy of Sciences, USA 92:2308–2312
MackewiczC. E.,
BarkerE.,
GrecoG.,
Reyes-TeranG.,
LevyJ. A.1997; Do β-chemokines have clinical relevance in HIV infection?. Journal of Clinical Investigation 100:921–930
MeyerL.,
MagierowskaM.,
HubertJ. B.,
RouziouxC.,
DeveauC.,
SansonF.,
DebreP.,
DelfraissyJ. F.,
TheodorouI.
and the SEROCO study group 1997; Early protective effect of CCR-5 ∆32 heterozygosity on HIV-1 disease progression: relationship with viral load. AIDS 11:F73–F78
NilssonC.,
MäkitaloB.,
ThorstenssonR.,
NorleyS.,
Binniger-SchinzelD.,
CranageM.,
RudE.,
BiberfeldG.,
PutkonenP.1998; Live attenuated simian immunodeficiency virus (SIV)mac in macaques can induce protection against mucosal infection with SIVsm. AIDS 12:2261–2270
OberlinE.,
AmaraA.,
BachelerieF.,
BessiaC.,
VirelizierJ. L.,
Arenzana-SeisdedosF.,
SchwartzO.,
HeardJ. M.,
Clark-LewisI.,
LeglerD. F.,
LoetscherM.,
BaggioliniM.,
MoserB.1996; The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382:833–835
PalR.,
Garzino-DemoA.,
MarkhamP. D.,
BurnsJ.,
BrownM.,
GalloR. C.,
DeVicoA. L.1997; Inhibition of HIV-1 infection by the β-chemokine MDC. Science 278:695–698
PaliardX.,
LeeA. Y.,
WalkerC. M.1996; RANTES, MIP-1α and MIP-1β are not involved in the inhibition of HIV-1SF33 replication mediated by CD8+ T-cell clones. AIDS 10:1317–1321
PutkonenP.,
NilssonC.,
WaltherL.,
GhavamzadehL.,
HildK.,
BrolidenK.,
BiberfeldG.,
ThorstenssonR.1994; Efficacy of inactivated whole vaccines with various adjuvants in cynomolgus monkeys. Journal of Medical Primatology 3:89–94
RosenbergE. S.,
BillingsleyJ. M.,
CaliendoA. M.,
BoswellS. L.,
SaxP. E.,
KalamsS. A.,
WalkerB. D.1997; Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 278:1447–1450
RubbertA.,
WeissmanD.,
CombadiereC.,
PettroneK. A.,
DaucherJ. A.,
MurphyP. A.,
FauciA. S.1997; Multifactorial nature of noncytolytic CD8 + T cell-mediated suppression of HIV replication: β-chemokine-dependent and -independent effects. AIDS Research and Human Retroviruses 13:63–69
WalkerC. M.,
MoodyD. J.,
StitesD. P.,
LevyJ. A.1989; CD8+ T lymphocyte control of HIV replication in cultured CD4 + cells varies among infected individuals. Cellular Immunology 119:470–475
WalkerC. M.,
Thomson-HonnebierG. A.,
HsuehF. C.,
EricksonA. L.,
PanL.-Z.,
LevyJ. A.1991; CD8+ T cells from HIV-1-infected individuals inhibit acute infection by human and primate immunodeficiency viruses. Cellular Immunology 137:420–428
ZaitsevaM.,
BlauveltA.,
LeeS.,
LaphamC. K.,
Klaus-KovtunV.,
MostowskiH.,
ManischewitsJ.,
GoldingH.1997; Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: implications for primary HIV infection. Nature Medicine 3:1369–1375
ZouW.,
LacknerA. A.,
SimsonM.,
Durand-GasselinI.,
GalanaudP.,
DesrosiersR. C.,
EmilieD.1997; Early cytokine and chemokine gene expression in lymph nodes of macaques infected with simian immunodeficiency virus is predictive of disease outcome and vaccine efficacy. Journal of Virology 71:1227–1236
β-chemokine production in macaques vaccinated with live attenuated virus correlates with protection against simian immunodeficiency virus (SIVsm) challenge